Sky Century Investment SKYI
OTC SKYI
$0.13 +0.02 (+18.18%)
At close: Aug 17, 2026 · 4:00 PM UTC

Sky Century Investment (SKYI) Assets Average (2013 - 2026)

Sky Century Investment (SKYI) posted quarterly Assets Average of $118579.5 for Q2 2026, up 25.95% year-over-year from $94147.5 in Q2 2025, and up 6.78% quarter-over-quarter from $111054.5 in Q1 2026.

Sky Century Investment (SKYI) Assets Average (2013 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has reported Assets Average for 4 consecutive years, with $118579.5 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Assets Average rose 25.95% year-over-year to $118579.5; the TTM figure through May 2026 stood at $118579.5 (up 25.95% YoY), while the FY2025 annual figure was $103563.0, up 115.98% from the prior year.
  • Assets Average rose to $118579.5 in Q2 2026 per SKYI's latest filing, from $111054.5 in the prior quarter.
  • Across five years, Assets Average topped out at $118579.5 in Q2 2026 and bottomed at $94147.5 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 43.72 Bn
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 39.95 Bn
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn 15.12 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 98.59 Bn
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn 6.97 Bn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 35.94 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 5.13 Bn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 13.39 Bn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - 5.97 Bn
10 Sky Century Investment 393,547.71 393,283.71 26,045.00 118,579.50

Historic Data

Download Data
DateValue
May 31, 2026 118,579.50
Feb 28, 2026 111,054.50
Nov 30, 2025 112,632.50
Aug 31, 2025 118,089.50
May 31, 2025 94,147.50
Aug 31, 2014 515.00
May 31, 2014 515.00
Feb 28, 2014 3,040.00
Nov 30, 2013 3,022.00
Aug 31, 2013 316.50